Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
Sanofi announced its intent to sell its equity investment in Regeneron (NASDAQ: REGN) through a registered public offering and related share repurchase by Regeneron. The registered offering and share repurchase will have no impact on the ongoing collaboration between Sanofi and Regeneron
Goro Healthcare signs distribution agreement with Avanzcare to become the exclusive distributor of Goro’s portfolio in Qatar
Goro Healthcare signs distribution agreement with industry leader – Avanzcare – to become the exclusive distributor in Qatar. Both companies will collaborate to bring to Qatari patients advanced healthcare products to treat several conditions such as chronic pain, IBS, hemorrhoids, and vaginal infections. Avanzcare is a unique business model serving the healthcare sector through pharmaceutical
TANYX® speed up recovery for Neymar to play against Colombia:
Neymar uses TANYX® to accelerate his recovery, three days before playing against Colombia on 04/06/2014 at the World Cup 2014 in Brazil. The Brazilian team won the Colombia 2-1
A patient with back pain was born again after using Perozin®:
Mogens Kondrup 56 years old man with back pain from neck to the lower back after an accident at work: “I tried everything, chiropractors, rheumatologists, physiotherapists, NSAID's, vallium etc… without getting any relieve from the unbearable constant pain. When I was advised to try Perozin®, I thought that is again the marketing that
UAE pharma firm Julphar makes pledge after product recall:
Pharmaceutical giant confirms recall of aspirin medicine by the UAE Ministry of Health and Prevention. UAE pharma firm Julphar makes pledge after product recall.
Julphar is one of the largest pharmaceutical manufacturers in the Middle East and Africa, has confirmed the recall of one of its products by the UAE Ministry of Health and
UAE pharma firm begins manufacturing ‘affordable’ generic medicines in Dubai:
Pharmax Pharmaceuticals, a UAE-based pharmaceutical company, has begun production of “affordable generic medicines” in its manufacturing facility located in Dubai Science Park. The facility received its Good Manufacturing Practice (GMP) licence in March 2018 and provides branded generic medications, which are affordable equivalents to brand-name drugs and have the same intended use, effects